Prime Editing CGD Cure B.C. | AcademicJobs.ca
Explore the historic cure of chronic granulomatous disease using prime editing in a B.C. patient, highlighting Canadian university research.
No reviews yet. Be the first to rate Stuart!
Stuart Turvey is a Professor in the Division of Immunology, Department of Pediatrics, Faculty of Medicine at the University of British Columbia. He holds the Tier 1 Canada Research Chair in Pediatric Precision Health, the O’Sullivan Family Hospital Chair in Precision Health Research at BC Children’s Hospital, and the Aubrey J. Tingle Professorship in Pediatric Immunology. Dr. Turvey earned his MBBS and DPhil degrees and is a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC). As a practicing pediatric clinical immunologist based at BC Children’s Hospital, his research program is translational and interdisciplinary, focusing on the role of innate immunity in infectious and inflammatory diseases of childhood, including primary immune deficiencies, asthma, allergies, and autoimmunity. His work employs detailed immunological, genomic, and proteomic analyses of children with defined disease phenotypes to identify underlying abnormalities, elucidate disease mechanisms, and develop precision health strategies.
Dr. Turvey leads efforts in microbiome cohort studies and precision medicine approaches to pediatric health challenges. He is affiliated with the BC Children’s Hospital Research Institute and contributes to research groups addressing childhood cancer and blood disorders, immunity in health and disease, origins of child health and disease, rare diseases, and vaccines, infections, and host defenses. His academic interests encompass immunodeficiencies, asthma, and the immune system. Dr. Turvey supervises graduate students in programs such as Experimental Medicine and Microbiology and Immunology at UBC. He has received recognition for his contributions to pediatric immunology and precision health research, including renewal of his Canada Research Chair position.
Explore the historic cure of chronic granulomatous disease using prime editing in a B.C. patient, highlighting Canadian university research.